Text Size

Outcome Analysis of the Oxford Partial Knee Arthroplasty

This study has been completed.
Sponsor:
Collaborator:
Dartmouth General Hospital
Information provided by (Responsible Party):
Biomet, Inc.
ClinicalTrials.gov Identifier:
NCT00759616
First received: September 24, 2008
Last updated: February 11, 2012
Last verified: February 2012
History of Changes
  Purpose

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty


Condition Intervention
Knee Arthroplasty
 Device: Oxford Partial Knee

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Outcome Analysis of the Oxford Partial Knee Arthroplasty

Resource links provided by NLM:

MedlinePlus related topics: Knee Replacement
U.S. FDA Resources

Further study details as provided by Biomet, Inc.:

Primary Outcome Measures:
  • WOMAC, SF12, oxford Knee,KSCRS [ Time Frame: 3weeks, 3months,6months, yearly ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Length of Hospital Stay [ Time Frame: Postop ] [ Designated as safety issue: No ]

Enrollment: 156
Study Start Date: April 2003
Study Completion Date: June 2009
Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1 Device: Oxford Partial Knee
Oxford Partial Knee

Detailed Description:

Utilization of systematic outcome measurements and specific designated time frames to monitor patient satisfactions will assist in analysing this type of prosthesis and the post operative period. Data collected will be added to the compiled information from previous studies in relation to the Oxford knee.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient Suitable for Knee Replacement

Exclusion Criteria:

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00759616

Locations
Canada
Dartmouth General Hospital
Dartmouth, Canada
Sponsors and Collaborators
Biomet, Inc.
Dartmouth General Hospital
  More Information

No publications provided

Responsible Party: Biomet, Inc.
ClinicalTrials.gov Identifier: NCT00759616     History of Changes
Other Study ID Numbers: BMET CA 03
Study First Received: September 24, 2008
Last Updated: February 11, 2012
Health Authority: Canada: Ethics Review Committee

Keywords provided by Biomet, Inc.:
Knee Replacement

ClinicalTrials.gov processed this record on May 16, 2013